Homart Takes Strategic Stake in ASX-Listed Wellnex Life
Family-owned health supplements maker and distributor Homart Pharmaceuticals takes a strategic stake in ASX-listed Wellnex Life. This makes if the second public listed company that Homart invests in this year 2022. Homart’s set to tip in $3 million into a $6 million deal, with funds raised to progress the group’s plans to get into over-the-counter […]
